You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Effects of Thiazolidinediones on development of macrovascular complications in type 2 Diabetes Mellitus
- In: Posters
- At: Amsterdam (the Netherlands) (2012)
- Type: Poster
- Poster code: CPS2-P-43
- By: SERDAREVIC, Lejla (Pharmacy Avicena, Visoko, Bosnia and Herzegovina)
- Co-author(s): Semiz Sabina, S. (University of Sarajevo, Faculty of Pharmacy, Sarajevo, Bosnia and Herzegovina)
- Abstract:
Type 2 diabetes mellitus (T2DM) is a chronic, metabolic disorder with an increased risk for developing macrovascular complications. In addition to life style modifications, different oral hypoglycemic agents are used to achieve optimal glycemic control in Type 2 diabetic patients. Thiazolidinediones (TZD's), pioglitazone and rosiglitazone, are
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026